RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
49 hedge funds and large institutions have $58.1M invested in Regulus Therapeutics in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
25% less capital invested
Capital invested by funds: $77.2M → $58.1M (-$19M)
Holders
49
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.19M | |
| 2 | +$1.07M | |
| 3 | +$1.05M | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$408K |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
+$104K |
Top Sellers
| 1 | -$6.55M | |
| 2 | -$2.9M | |
| 3 | -$427K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$255K |
| 5 |
QIM
Quantitative Investment Management
Charlottesville,
Virginia
|
-$135K |